PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,000 | +60.0% | 6,486 | +61.2% | 0.00% | – |
| Q2 2023 | $25,000 | +150.0% | 4,024 | +94.7% | 0.00% | – |
| Q1 2023 | $10,000 | -76.2% | 2,067 | -57.3% | 0.00% | – |
| Q4 2022 | $42,000 | +740.0% | 4,837 | +977.3% | 0.00% | – |
| Q3 2022 | $5,000 | +66.7% | 449 | +116.9% | 0.00% | – |
| Q2 2022 | $3,000 | -91.2% | 207 | -87.2% | 0.00% | – |
| Q1 2022 | $34,000 | -75.5% | 1,611 | -73.2% | 0.00% | – |
| Q4 2021 | $139,000 | +104.4% | 6,006 | +163.3% | 0.00% | – |
| Q3 2021 | $68,000 | +9.7% | 2,281 | +24.8% | 0.00% | – |
| Q2 2021 | $62,000 | +72.2% | 1,828 | +67.2% | 0.00% | – |
| Q1 2021 | $36,000 | +38.5% | 1,093 | +163.4% | 0.00% | – |
| Q4 2020 | $26,000 | – | 415 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 3,869,911 | $115,323,000 | 47.76% |
| Euclidean Capital LLC | 2,769,813 | $82,540,000 | 40.12% |
| Logos Global Management LP | 1,400,000 | $41,720,000 | 3.01% |
| Orbimed Advisors | 7,330,423 | $218,447,000 | 2.40% |
| Boxer Capital, LLC | 2,268,236 | $67,593,000 | 2.36% |
| PERSONAL CFO SOLUTIONS, LLC | 355,342 | $10,589,000 | 2.17% |
| Asymmetry Capital Management, L.P. | 100,882 | $3,006,000 | 1.81% |
| Avoro Capital Advisors LLC | 2,925,000 | $87,165,000 | 1.37% |
| COMMODORE CAPITAL LP | 125,000 | $3,725,000 | 0.98% |
| HighVista Strategies LLC | 39,777 | $1,185,000 | 0.78% |